Pain classification meeting
This article was originally published in The Tan Sheet
FDA Arthritis Advisory Committee will meet July 29-30 at the Holiday Inn in Bethesda, Md. to discuss acute and chronic pain subcategories. Agency is planning to create three subcategories within the two current groupings of acute and chronic pain. Committee will discuss clinical relevance of different pain classifications, appropriate clinical trial models and designs for drugs indicated for each classification...
You may also be interested in...
Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics.
The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.
Limiting interactions to two-dimensional settings will hinder collaboration, innovation and the mentoring of younger employees, Merck & Co. CEO Kenneth Frazier says. Frazier, who will retire in June, is looking forward to returning to public service but says "politics with a capital P is not my thing."